TISHA KAMROWSKI: Open Payments
NPI 1114558830 · MINOT, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 18 payments from 7 companies in 2025. Trend: 2023 $16 · 2024 $221 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $97 |
| ABBVIE INC. | 6 | $90 |
| Alkermes, Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: CAPLYTA, VRAYLAR, REXULTI, ARISTADA, Auvelity, LYBALVI, TRINTELLIX.
Industry payments across ND — which companies pay providers there.
